Results

Total Results: 2,228 records

Showing results for "disease".

141. Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia_research.pdf
     January 01, 2013 - has asymptomatic disease), diagnosis (who has symptomatic disease), staging (how advanced is the disease … disease). … American Journal of Kidney Diseases 1997 Dec;30(6):814-21. PMID: 9398126. 17. … American Journal of Kidney Diseases 1999 Jul;34(1):29-35. PMID: 10401012. 24. … American Journal of Kidney Diseases 1997 Dec;30(6):912-22. PMID: 9398141. 33.

142. Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_disposition-comments.pdf
     March 29, 2016 - Disposition of Comments for CER 171 Noninvasive Testing for Coronary Artery Disease Comparative Effectiveness … Noninvasive Testing for Coronary Artery Disease. Comparative Effectiveness Review No. 171. … Outcomes of anatomical versus functional testing for coronary artery disease. … and patients who have some coronary disease. … Outcomes of anatomical versus functional testing for coronary artery disease.

143. Future Research Needs for Angiotensin Converting Enzyme Inhibitors or Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/heart-disease-ace-inhibitor-arb-future/research

144. Transparency of Reporting Requirements: Omega-3 Fatty Acids and Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-omega-3_research-protocol.pdf
     September 02, 2016 - , rx, ui, tx, kw, ct, sh, bt, id, cc] n-3 B iom arkers 24. or/1-23 n-3 25. exp cardiovascular diseases … / C ardiovascular diseases, risk factors, adverse events 26. atherosclero$.mp. … , ot, ab, nm, hw, kw, kf, px, rx, ui, an, tx, sh, ct, bt, id, cc] 62. exp peripheral vascular diseases … (peripheral and vascular and disease$).mp. … (eg, cancer, gastrointestinal disease, dialysis, chronic renal failure, rheumatic disease) or condition

145. Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_executive.pdf
     August 01, 2016 - oil supplements do not change one’s risk of several cardiovascular diseases (including overall major … macronutrient distribution range (a range of intakes that is associated with reduced risk of chronic diseases … Who are the participants (i.e., what is the population and setting of interest, including the diseases … (e.g., cancer, gastrointestinal disease, rheumatic disease, dialysis) Interventions/Exposures • … diagnosis o Cerebrovascular disease, new diagnosis o Peripheral vascular disease, new diagnosis

146. Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
     February 01, 2013 - ”[MeSH Terms] OR (“cardiovascular”[All Fields] AND “diseases”[All Fields]) OR “cardiovascular diseases … ”[All Fields]) OR (“heart diseases”[MeSH Terms] OR (“heart”[All Fields] AND “diseases”[All Fields]) … exp OR ‘unstable angina pectoris’/exp OR ‘cardiovascular diseases’:ab OR ‘heart diseases’:ab OR heart … "[MeSH Terms] OR ("cardiovascular"[All Fields] AND "diseases"[All Fields]) OR "cardiovascular diseases … "[All Fields]) OR ("heart diseases"[MeSH Terms] OR ("heart"[All Fields] AND "diseases"[All Fields])

147. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer18-heart-disease-ace-inhibitor-arb-executive.pdf
     October 01, 2009 - Cardiovascular disease claims more lives each year than cancer, chronic lower respiratory diseases, accidents … In patients with stable ischemic heart disease or ischemic heart disease risk equivalents who have preserved … In patients with stable ischemic heart disease or ischemic heart disease risk equivalents who have preserved … In patients with stable ischemic heart disease or ischemic heart disease risk equivalents who have preserved … cannot be determined at this time. 1 The JMIC-B (Japan Multicenter Investigation for Cardiovascular Diseases-B

148. Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/fatty-acids-cardiovascular-disease_disposition-comments.pdf
     August 12, 2016 - Omega-3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review Source: https://www.effectivehealthcare.ahrq.gov … Assessment Disposition of Comments Report Research Review Title: Omega-3 Fatty Acids and Cardiovascular Disease … Omega−3 Fatty Acids and Cardiovascular Disease: An Updated Systematic Review. … job was done in identifying the three major study populations: healthy adults without cardiovascular disease … appreciate the opportunity to provide comments on the draft report “Omega-3 Fatty Acids and Cardiovascular Disease

149. Mixed MethodsReview -Integrating Palliative Care with Chronic Disease Management in Ambulatory Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/palliative-care-research-amended-protocol.pdf
     November 21, 2019 - Mixed MethodsReview -Integrating Palliative Care with Chronic Disease Management in Ambulatory Care … (Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria III or IV), end- stage renal … disease, frailty and multiple serious chronic conditions. … disease, frailty and multiple serious chronic conditions. … A taxonomy for disease management: a scientific statement from the American Heart Association Disease

150. - (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease-future_research.pdf
     July 01, 2016 - history of the disease. … by the AGA9 including the introduction of biologics into the treatment algorithm for inflammatory diseases … history of the disease. … by the AGA9 including the introduction of biologics into the treatment algorithm for inflammatory diseases … Review article: Crohn's disease: monitoring disease activity.

151. Appendix A - The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease-appendix-a.pdf
     August 31, 2023 - Appendix A - The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease … Citations, Daily and Versions 1946 to August 31, 2023 Search Strategy: # Searches 1 exp Cardiovascular Diseases … cerebrovascular) adj3 ("adverse event*" or anomaly or anomalies or abnormalit* or defect or defects or disease … 37 remove duplicates from 36 38 33 or 35 or 37 ClinicalTrials.Gov Condi�on or Disease … Cardiovascular disease Other terms "2-Hydroxypropyl-beta-cyclodextrin" OR "alimentary carbohydrate

152. Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/peripheral-artery-disease-treatment_disposition-comments.pdf
     May 29, 2013 - Disposition of Comments for Treatment Strategies for Patients With Peripheral Artery Disease … Comments Report Research Review Title: Treatment Strategies for Patients With Peripheral Artery Disease … Treatment Strategies for Patients With Peripheral Artery Disease. … The gaps and disease specific limitation section was particularly nice. … Dietary cholesterol and egg yolks: Not for patients at risk of vascular disease.

153. Evidence Report on the (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
     September 01, 2010 - ’s disease are at risk for growth retardation in the absence of adequately treated disease. … Our search strategy for MEDLINE is: (“Crohn Disease”[mh] OR “Crohn’s Disease”[tiab] OR “Crohn Disease … [tiab] OR colitis[tiab])) OR “inflammatory bowel diseases”[mh] OR “inflammatory bowel disease”[tiab] … OR “inflammatory bowel diseases”[tiab] OR IBD[tiab]) AND (“Aminosalicylic acids”[mh] OR “Anti- inflammatory … Disease activity courses in a regional cohort of Crohn's disease patients.

154. FRN 41 - Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cad-women-diagnosis-future_research_1.pdf
     February 01, 2013 - [mesh] OR "coronary artery disease"[tiab] OR coronary disease[mesh] OR "coronary disease"[tiab] OR " … [mesh] OR "coronary artery disease"[tiab] OR coronary disease[mesh] OR "coronary disease"[tiab] OR " … '/exp OR 'ischemic heart disease'/exp OR cad OR 'coronary artery disease' OR 'coronary disease' OR ' … , peripheral vascular disease, diabetes, chronic kidney disease, or congestive heart failure. … ICD-9 (International Classification of Diseases, Ninth Revision) and CPT (Current Procedural Terminology

155. Disposition of Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
     August 11, 2014 - Comments Report for Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients Wtih Kidney Disease … Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease. … to the severity of chronic kidney disease or is there a threshold effect? … Is this due to kidney disease alone? Does this portend increased cardiovascular risk? … Many studies did not adjust for age, history of coronary artery disease, comorbidities, etc.

156. Executive Summary_The Effect of Protein Intake on Health: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-protein-intake-executive-summary.pdf
     November 01, 2024 - , kidney disease, and sarcopenia risks is insufficient and inconclusive. … for bone, kidney disease, and sarcopenia diagnostic components. … reference value for chronic disease risk reduction. … Limitations Our systematic review had several strengths, including a unique emphasis on multiple chronic diseases … and sarcopenia, which may not fully reflect the presence and progression of chronic diseases, diverse

157. Disposition of Comments_Systematic Review: The Relationship of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, and Body Composition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/effect-dietary-digestible-disposition-comments_0.pdf
     March 03, 2025 - Comments_Systematic Review: The Relationship of Digestible Carbohydrate Intake With Cardiovascular Disease … Disposition of Comments Report Title: Association of Digestible Carbohydrate Intake With Cardiovascular Disease … Association of Digestible Carbohydrate Intake With Cardiovascular Disease, Type 2 Diabetes, Obesity, … The numbers of adolescents with type II diabetes are increasing and certainly many of these disease … I would have liked to see the relevance of the review for the development of the chronic disease risk

158. Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/fatty-acids-cardiovascular-disease_clinician.pdf
     July 01, 2017 - Omega-3 Fatty Acids and Cardiovascular Disease: Current State of the Evidence Omega-3 Fatty Acids and … Cardiovascular Disease: Current State of the Evidence Focus of This Summary This is a summary of … Heart and Blood Vessel Conditions Heart Disease Background The first observation of a link between … Source The information in this summary is based on Omega-3 Fatty Acids and Cardiovascular Disease: An … Effects of omega-3 fatty acids on cardiovascular disease.

159. Ácidos grasos omega-3 y la enfermedad cardiovascular | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/fatty-acids-cardiovascular-disease/espanol

160. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
     September 01, 2011 - , persistently active disease, mortality). … in the natural history of the disease complicate the measurement of disease activity and treatment effects … The ACR Pediatric 30 is also a relative measure of disease activity and not a measure of current disease … The heterogeneity in disease severity and the broad impact of the disease on both physical and psychosocial … describe overall disease status.